Maze Therapeutics, Inc. · NASDAQ:MAZE

Coloma Jason V sold 32,564 Maze Therapeutics, Inc. shares (Form 4)

Traded May 22 to May 26, 2026 · Filed May 27, 2026

From May 22 to May 26, 2026, Coloma Jason V (Director, Chief Executive Officer) sold 32,564 Maze Therapeutics, Inc. shares at an average US$26.02 for US$847K under a trading plan, leaving 350,987 shares. Filed May 27, 2026 (Form 4).

Sold
32,564 shares
Price
US$26.02 average (US$26.00 to US$26.02)
Value
US$847K
Holding after
350,987 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 22, 2026Common StockSale4,504US$26.00376,569Indirect
May 22, 2026Common StockSale2,478US$26.0028,523Indirect
May 26, 2026Common StockSale25,582US$26.02350,987Indirect

Source

View original at SEC

Related